Emergency COVID-vaccine approvals pose a dilemma for scientists. It could complicate efforts to study long-term outcomes, such as safety, how long protection lasts and whether the jab prevents infection or just the disease
24 Nov, 2020 | 09:28h | UTCWhy emergency COVID-vaccine approvals pose a dilemma for scientists – Nature